Uncovering the Genetic Basis of Glioblastoma Heterogeneity through Multimodal Analysis of Whole Slide Images and RNA Sequencing Data

Ahmad Berjaoui,Louis Roussel,Eduardo Hugo Sanchez,Elizabeth Cohen-Jonathan Moyal
2024-10-23
Abstract:Glioblastoma is a highly aggressive form of brain cancer characterized by rapid progression and poor prognosis. Despite advances in treatment, the underlying genetic mechanisms driving this aggressiveness remain poorly understood. In this study, we employed multimodal deep learning approaches to investigate glioblastoma heterogeneity using joint image/RNA-seq analysis. Our results reveal novel genes associated with glioblastoma. By leveraging a combination of whole-slide images and RNA-seq, as well as introducing novel methods to encode RNA-seq data, we identified specific genetic profiles that may explain different patterns of glioblastoma progression. These findings provide new insights into the genetic mechanisms underlying glioblastoma heterogeneity and highlight potential targets for therapeutic intervention.
Quantitative Methods,Artificial Intelligence
What problem does this paper attempt to address?
The paper attempts to address the issue of uncovering the genetic basis and heterogeneity of Glioblastoma (GB). Despite advances in treatment, the highly invasive nature and poor prognosis of glioblastoma remain poorly understood. Specifically, this study explores the heterogeneity of glioblastoma through a multimodal deep learning approach, combining Whole Slide Images (WSI) and RNA sequencing data (RNA-seq). ### Main Objectives: 1. **Identify potential genetic markers associated with glioblastoma invasiveness**: Through a multimodal deep learning approach, researchers aim to find new genes and genetic features that may explain the progression patterns of different glioblastomas. 2. **Develop new RNA-seq encoding techniques**: Researchers propose a pathway-based RNA-seq encoding method to improve the performance of deep learning models. 3. **Combine WSI and RNA-seq data**: Researchers develop a new method to integrate WSI and RNA-seq data for deep learning models to better understand the genetic heterogeneity of glioblastoma. ### Background: - **Glioblastoma**: A highly invasive brain tumor characterized by rapid progression and poor prognosis. - **Existing treatments**: Include surgery, chemoradiotherapy, and recently Tumor Treating Fields, but the median overall survival is only 20.9 months, with a progression-free survival of about 7 months. - **Tumor Stem Cells (GSCs)**: Believed to be the main driver of glioblastoma's biological heterogeneity, potentially leading to high recurrence rates. ### Methods: - **Dataset**: Utilized public data from The Cancer Genome Atlas (TCGA) and WSI and RNA-seq data from the STEMRI trial. - **RNA-seq encoding**: Based on Protein-to-Protein Interaction (PPI) maps, genes are clustered and then encoded. - **WSI encoding**: Images are segmented into non-overlapping patches and encoded using contrastive learning methods. - **Multimodal training**: Combined RNA-seq and WSI data, using a multimodal contrastive loss function to train the model. ### Results: - **Genetic markers**: Identified known and new genes associated with glioblastoma invasiveness. - **Encoding techniques**: The proposed pathway-based RNA-seq encoding method showed better performance. - **Multimodal model**: Successfully integrated WSI and RNA-seq data, enhancing the understanding of glioblastoma's genetic heterogeneity. ### Significance: - **Personalized medicine**: These findings provide new targets for developing personalized treatment strategies for glioblastoma patients. - **Continued research**: Emphasizes the importance of applying AI algorithms in cancer biology, providing direction for further research. In summary, this paper reveals the genetic basis and heterogeneity of glioblastoma through a multimodal deep learning approach, combining image and gene expression data, offering new insights for future treatments.